JO
AXDX

John Overdeck’s Accelerate Diagnostics AXDX Stock Holding History

John Overdeck’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,136
Closed -$22K – 3004
2023
Q1 		$22K Sell
3,136
-6,296
-67% -$37.9K ﹤0.01% 2845
2022
Q4 		$66.6K Sell
9,432
-12,242
-56% -$134K ﹤0.01% 2560
2022
Q3 		$329K Buy
+21,674
New +$359K ﹤0.01% 1936
2022
Q2 		– Sell
-25,169
Closed -$362K – 2505
2022
Q1 		$362K Sell
25,169
-4,485
-15% -$128K ﹤0.01% 2150
2021
Q4 		$1.55M Buy
29,654
+28,331
+2,141% +$1.58M ﹤0.01% 2154
2021
Q3 		$77K Buy
+1,323
New +$86.3K ﹤0.01% 4110
2021
Q2 		– Sell
-5,547
Closed -$462K – 4035
2021
Q1 		$462K Sell
5,547
-16,153
-74% -$1.64M ﹤0.01% 2996
2020
Q4 		$1.65M Buy
21,700
+17,357
+400% +$1.55M ﹤0.01% 1617
2020
Q3 		$463K Buy
4,343
+1,855
+75% +$258K ﹤0.01% 2306
2020
Q2 		$377K Sell
2,488
-12,318
-83% -$1.21M ﹤0.01% 2212
2020
Q1 		$1.23M Buy
14,806
+9,532
+181% +$1.34M 0.01% 1268
2019
Q4 		$891K Buy
+5,274
New +$870K ﹤0.01% 2292

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

John Overdeck's AXDX Position: Q2 2023 in Review

John Overdeck sold out of Accelerate Diagnostics (AXDX) in Q2 2023, closing a stake of 3,136 shares — an estimated $22K sold.

John Overdeck first reported a position in AXDX in Q4 2019 and held it in 12 quarters. The position peaked at $1.65M in Q4 2020. 50 funds tracked by Wall St. Rank hold AXDX as of Q2 2023.

  • John Overdeck reported no remaining Accelerate Diagnostics position as of Q2 2023 after selling out during the quarter.
  • John Overdeck sold 3,136 Accelerate Diagnostics shares in Q2 2023, an estimated $22K.
  • John Overdeck first reported a position in Accelerate Diagnostics in Q4 2019 and held it in 12 quarters.
  • John Overdeck's Accelerate Diagnostics position peaked at $1.65M in Q4 2020.
  • 50 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.